| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Sapir Alex is a See Remarks at FULC. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $632K at current prices.
Sapir Alex's largest disclosed position is in FULC as See Remarks, worth about $632K. Net of sales, the recent Form 4 record there shows accumulation of 43,360 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Buy | 43,360 | $11.35 | $492,027.60 | New | -27.8% | -71.1% |